Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP219548.RA9iRwnuxXa1QvQ_ce5aVegZMM-2vhIGR791KmSmO395I130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP219548.RA9iRwnuxXa1QvQ_ce5aVegZMM-2vhIGR791KmSmO395I130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP219548.RA9iRwnuxXa1QvQ_ce5aVegZMM-2vhIGR791KmSmO395I130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP219548.RA9iRwnuxXa1QvQ_ce5aVegZMM-2vhIGR791KmSmO395I130_provenance.
- NP219548.RA9iRwnuxXa1QvQ_ce5aVegZMM-2vhIGR791KmSmO395I130_assertion description "[In addition, we found that cells with copy number enhancement of v-abl Abelson murine leukemia viral oncogene homolog 2 (ABL2) and ephrin receptor kinase and v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) (SRC) kinase family genes were exquisitely sensitive to treatment with the SRC/ABL inhibitor dasatinib, both in vitro and when it xenografted into mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219548.RA9iRwnuxXa1QvQ_ce5aVegZMM-2vhIGR791KmSmO395I130_provenance.
- NP219548.RA9iRwnuxXa1QvQ_ce5aVegZMM-2vhIGR791KmSmO395I130_assertion evidence source_evidence_literature NP219548.RA9iRwnuxXa1QvQ_ce5aVegZMM-2vhIGR791KmSmO395I130_provenance.
- NP219548.RA9iRwnuxXa1QvQ_ce5aVegZMM-2vhIGR791KmSmO395I130_assertion SIO_000772 19451690 NP219548.RA9iRwnuxXa1QvQ_ce5aVegZMM-2vhIGR791KmSmO395I130_provenance.
- NP219548.RA9iRwnuxXa1QvQ_ce5aVegZMM-2vhIGR791KmSmO395I130_assertion wasDerivedFrom befree-20150227 NP219548.RA9iRwnuxXa1QvQ_ce5aVegZMM-2vhIGR791KmSmO395I130_provenance.
- NP219548.RA9iRwnuxXa1QvQ_ce5aVegZMM-2vhIGR791KmSmO395I130_assertion wasGeneratedBy ECO_0000203 NP219548.RA9iRwnuxXa1QvQ_ce5aVegZMM-2vhIGR791KmSmO395I130_provenance.
- befree-20150227 importedOn "2015-02-27" NP219548.RA9iRwnuxXa1QvQ_ce5aVegZMM-2vhIGR791KmSmO395I130_provenance.